Lorillee C Tallorin et al.
Bioorganic & medicinal chemistry, 22(21), 6053-6061 (2014-10-07)
Enoyl-acyl carrier protein reductase (ENR), a critical enzyme in type II fatty acid biosynthesis, is a promising target for drug discovery against hepatocyte-stage Plasmodium falciparum. In order to identify PfENR-specific inhibitors, we docked 70 FDA-approved, bioactive, and/or natural product small